Microfluidic Method Boosts Cell Conversion Efficiency
A new physical compression technique allows researchers to convert skin cells into neurons with significantly higher efficiency.
Updated on Oct. 28, 2026 in Life Sciences

Live Poll
Should scientists prioritize aggressive genetic engineering techniques to treat human diseases?
UCLA researchers have developed Mechanically Enhanced CRISPR Activation (MECA), a research-stage method that uses physical compression to improve the conversion of skin cells into neurons. By forcing cells through microfluidic channels, the process increases the accessibility of target DNA for reprogramming.
Why it matters
This development addresses a critical bottleneck in cellular reprogramming where dense chromatin packing prevents gene-editing tools from accessing target sequences. The research suggests mechanical stress can significantly improve the efficiency of artificial cell conversion, a key requirement for future regenerative medicine applications.
The MECA method forces cells through microfluidic channels narrower than their nuclei for milliseconds, disrupting chromatin rigidity to improve DNA receptivity. This mechanical approach achieved a 10% conversion rate in mouse skin cells, compared to the 3% baseline for standard CRISPRa.
The players
UCLA
A major public research university with significant output in biotechnology and cellular engineering.
The details
MECA works by subjecting cells to rapid mechanical deformation as they pass through narrow microfluidic channels. This physical stress effectively loosens chromatin, the tightly packed complex of DNA and proteins that often blocks the access of CRISPRa (CRISPR activation, a tool used to increase the expression of specific genes) machinery to target DNA. Once the chromatin is more receptive, the protocol targets the genes Ascl1, Brn2, and Oct4 to initiate the conversion into neurons.
Timeline
October 28, 2026: Study on the MECA method published in Matter.
The Tech Race
This research follows a pattern of improving CRISPRa techniques by solving the chromatin accessibility problem that limits standard gene-activation tools. It marks a shift toward physical, rather than purely chemical, methods for overcoming biological barriers in cellular reprogramming.
This method is currently limited to laboratory research in mice and is not available for clinical use. Future development will focus on testing the process in human cells to evaluate its potential for regenerative medicine applications.
The takeaway
The MECA study demonstrates that physical force can be a powerful lever to improve gene-editing efficiency in research settings. Observers should track subsequent findings on human-cell testing to determine if this mechanical approach scales toward practical therapeutic use.
Further reading
For broader trends in cellular engineering, explore the latest updates from Life Sciences.
Source note: This article includes information reported by PravdaReport.
Live Poll
Should scientists prioritize aggressive genetic engineering techniques to treat human diseases?





